Alector to Participate in the TD Cowen 46th Annual Health Care Conference
Alector (Nasdaq: ALEC) said management will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 3:10 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alector (Nasdaq: ALEC) said management will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 3:10 PM ET. A live webcast will be available on the company’s Investors “Events & Presentations” page, with a replay accessible for 90 days.
Details
News Market Reaction – ALEC
On Feb 24, the day this news came out, ALEC closed 4.29% above the previous close.
Data tracked by StockTitan Argus for the Feb 24 session.
Key Figures
- Conference date
- March 3, 2026
- TD Cowen 46th Annual Health Care Conference corporate presentation
- Presentation time
- 3:10 pm ET
- Scheduled time for ALEC corporate presentation
- Webcast replay window
- 90 days
- Replay availability on Alector’s investor website after the event
- Price change 24h
- 5.53%
- Move ahead of/around TD Cowen conference participation news
- 52-week high
- $3.3999
- Pre-news 52-week high level for ALEC
- 52-week low
- $0.87
- Pre-news 52-week low level for ALEC
Historical Context
-
Neil Berkley named permanent CFO and continues as Chief Business Officer.
-
Management participation in Bank of America CNS Therapeutics Conference.
-
Q3 2025 results, cash runway into 2027, ABC programs and trial updates.
-
Latozinemab Phase 3 failed clinical endpoint; workforce reduction and portfolio shift.
-
Virtual R&D event on PGRN franchise and ABC programs across neuro indications.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in a corporate presentation at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 3:10 pm ET.
A live webcast of the corporate presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com. A replay will be available on the Alector website for 90 days following the event.
About Alector
Alector is a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. Leveraging the principles of genetics, immunology, and neuroscience, the company is advancing a portfolio of programs that aim to remove toxic proteins, replace missing proteins, and restore immune and nerve cell function. Supported by biomarkers, Alector’s product candidates seek to treat a range of indications, such as Alzheimer’s disease, Parkinson's disease, and frontotemporal dementia. The company is also developing Alector Brain Carrier (ABC), a proprietary blood-brain barrier platform, which is being selectively applied to its preclinical and research pipeline. ABC aims to enhance the delivery of therapeutics, achieve deeper brain penetration and efficacy at lower doses, and ultimately improve patient outcomes while reducing costs. Alector is headquartered in South San Francisco, California. For more information, please visit www.alector.com.
Alector Contacts:
Argot Partners (media)
David Rosen
(212) 600-1494
alector@argotpartners.com
Argot Partners (investors)
Laura Perry
(212) 600-1902
alector@argotpartners.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.